On Feb 28, 2022 Stämm Biotech closed a Series A round and raised $17,000,000 from Decarbonization Consortium, Dragones VC, Draper Associates, Draper Cygnus, GRID EXPONENTIAL, […]
Post-IPO Equity – BioVaxys
On Feb 28, 2022 BioVaxys closed a Post-IPO Equity round and raised $798,500 from investors, featuring lead investors . About the company: BioVaxys is located […]
Series C – SeLux Diagnostics
On Feb 28, 2022 SeLux Diagnostics closed a Series C round and raised $50,000,000 from Northpond Ventures, RA Capital Management, Sands Capital, Schooner Capital, featuring […]
Funding Round – Cell-Easy
On Feb 28, 2022 Cell-Easy closed a Funding Round round and raised €7,800,000 from Bpifrance, Région Occitanie, featuring lead investors Bpifrance. About the company: Cell-Easy […]
Series C – Biomason
On Feb 28, 2022 Biomason closed a Series C round and raised $65,000,000 from 2150, Celesta Capital, Hartree Partners, Martin Marietta, Novo Holdings, featuring lead […]
Series C – SeLux Diagnostics
On Feb 28, 2022 SeLux Diagnostics closed a Series C round and raised $50,000,000 from Northpond Ventures, RA Capital Management, Sands Capital, Schooner Capital, featuring […]
Funding Round – Cell-Easy
On Feb 28, 2022 Cell-Easy closed a Funding Round round and raised €7,800,000 from Bpifrance, Région Occitanie, featuring lead investors Bpifrance. About the company: Cell-Easy […]
Series A – Engimmune Therapeutics
On Feb 21, 2022 Engimmune Therapeutics closed a Series A round and raised CHF500,000 from BaseLaunch, featuring lead investors BaseLaunch. About the company: Engimmune Therapeutics […]
Seed Round – Neucruit
On Feb 21, 2022 Neucruit closed a Seed round and raised $1,000,000 from investors, featuring lead investors . About the company: Neucruit is located at […]
Post-IPO Equity – Jagsonpal Pharmaceuticals
On Feb 21, 2022 Jagsonpal Pharmaceuticals closed a Post-IPO Equity round and raised ₹2,690,000,000 from Convergent Finance, featuring lead investors Convergent Finance. About the company: […]
